Characteristics | Arm 1: HCQ + SOC | Arm 2: SOC alone | Total |
---|---|---|---|
Total randomized and analyzed | 55 | 50 | 105 |
Age in years | Â | Â | Â |
Median (IQR) | 30 (26–44) | 32 (27–42) | 32 (27–43) |
Range | 18–64 | 20–59 | 18–64 |
Age categories, n (%) | Â | Â | Â |
18–34 | 29 (52.7) | 28 (56.0) | 57 (54.3) |
35–59 | 25 (45.5) | 22 (44.0) | 47 (44.8) |
 ≥ 60 | 1 (1.8) | 0 | 1 (0.9) |
Sex, n (%) | Â | Â | Â |
Male | 39 (70.9) | 37 (74.0) | 76 (72.4) |
Female | 16 (29.1) | 13 (26.0) | 29 (27.6) |
Baseline SARS COV-2 CT-valuesa | Â | Â | Â |
Number of observations | 17 | 17 | 34 |
Mean (SD) | 19.0 (5.1) | 18.9 (4.9) | 18.9 (4.9) |
Median (IQR) | 18.8 (16.1–23.0) | 19.9 (14.8–22.4) | 19.6 (14.8–23.0) |
Range (minimum–maximum) | 9.6–27.1 | 9.6–25.5 | 9.6–27.1 |
Comorbidity, n (%) | Â | Â | Â |
High blood pressureb | 2 (3.6) | 1 (2.1) | 3 (2.9) |
Heart disease | 1 (1.8) | 0 | 1 (0.9) |
Diabetesb | 2 (3.5) | 1 (2.0) | 3 (2.8) |
Cigarette smokingb | 2 (3.6) | 0 | 2 (1.9) |
Alcohol dependencyb | 7 (12.3) | 6 (12.5) | 13 (12.4) |
HIV positiveb | 3 (5.4) | 2 (4.1) | 5 (4.8) |